Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Sarcoma 8Neuroectodermal Tumors, Primitive, Peripheral 4Wilms Tumor 3Malignant mesenchymal tumor 3Kidney Neoplasms 3Rhabdomyosarcoma 2Liposarcoma 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Fibrosarcoma 2Desmoplastic Small Round Cell Tumor 2Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Ovarian Neoplasms 1Neoplasms 1Chondrosarcoma 1

Interventions

Radiotherapy 2Ifosfamide 2HhAntag691 2Doxorubicin 2tanespimycin 1enasidenib 1alanosine 1Vincristine 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Neoadjuvant Therapy 1Gelclair 1Filgrastim 1Etoposide 1Epirubicin 1Dactinomycin 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Carboplatin 13-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Chondrosarcoma × Dactinomycin × Clear all
NCT00025441 2013-12-04

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

National Cancer Institute (NCI)

Phase 2 Completed
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Ovarian Neoplasms, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡